NeuroSense Therapeutics ratios data for the quarter ended Dec 2025. These financial ratios cover 15 quarters of results from Dec 2021 through Dec 2025, standardized by Business Quant from the company’s SEC filings.
| Ratios | Dec2021 | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Jun2025 | Dec2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Efficiency | |||||||||||||||
| Assets AverageAssets Avg. | 6.11M | 12.89M | 12.90M | 10.34M | 8.47M | 6.53M | 6.60M | 6.63M | 4.29M | 2.32M | 1.64M | 1.41M | 2.78M | 3.13M | 1.36M |
| Leverage & Solvency | |||||||||||||||
| Interest Coverage RatioInterest Cover | -0.81 | 141.91 | 102.57 | 331.90 | -3.93 | 9.65 | 1.79 | 218.83 | -1.15 | ||||||
| Times Interest Earned | -0.81 | 141.91 | 102.57 | 331.90 | -3.93 | 9.65 | 1.79 | 218.83 | -1.15 | ||||||
| Return Ratios | |||||||||||||||
| Return on Capital Employed [ROCE]ROCE | -96.70% | -156.41% | -217.22% | -279.74% | -245.36% | -1,457.83% | 543.01% | 628.16% | 472.18% | -1,257.40% | |||||
| Return on Assets [ROA]ROA | -40.45% | -125.63% | -162.35% | -135.41% | -67.56% | -336.93% | -639.78% | -978.95% | -1,393.56% | -356.25% |
Pull NeuroSense Therapeutics's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=NRSN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "NRSN", "statement": "Ratios", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=NRSN&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();